Firide

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Firide

Firide is a prescription pharmaceutical containing the active ingredient Finasteride, which is solely indicated for use in adult men. This medicine is defined as an orally administered, single-agent product supplied as a film-coated tablet. Its fundamental purpose is to modulate hormonal activity related to specific conditions in male patients.

Property Description
Active ingredient Finasteride
Form Film-coated tablet
Pharmacological class 5α-reductase inhibitor
General purpose Manages androgen-dependent disorders
Origin Synthetic 4-azasteroid compound

What is the Active Ingredient and Class of Firide?

Firide's core active substance is Finasteride (INN), a synthetic 4-azasteroid compound that is chemically derived from the steroid structure. This compound is classified within the drug group of 5α-reductase inhibitors, a therapeutic categorization that specifies the medicine's unique molecular target. This class is recognized for its targeted action.

As a solid pharmaceutical preparation, Firide is designed for oral administration, ensuring its systemic action across the body. Finasteride is an orally active drug, which facilitates its absorption into the bloodstream. The compound is defined by its role as an inhibitor of 5α-reductase.

How Does Finasteride Work to Offer General Benefit?

The high-level principle guiding Finasteride’s action is selective hormone blocking through enzyme inhibition. The compound works by acting as a highly specific inhibitor of the 5α-reductase enzyme, which is the biological catalyst for converting the male hormone testosterone into the more potent androgen dihydrotestosterone (DHT).

The overall benefit of this action is the resulting reduction in DHT concentration, which mitigates the potent hormonal stimulus responsible for promoting the progression of certain androgen-dependent disorders in men. The efficacy of the compound is linked to this reduction in circulating DHT levels. By diminishing the influence of DHT on sensitive tissues, this targeted biochemical intervention serves as a means of managing the underlying cause of these specific conditions.

Regulatory References

  1. NIH Finasteride information
  2. NIH 5α-Reductase Inhibitors
  3. EMA Finasteride referral

What side effects are possible with Firide?

Possible Side Effects and Safety Information for Firide

Adverse reactions associated with Firide are generally categorized by the system organ class affected and their reported frequency. Officially documented side effects commonly involve sexual dysfunction and psychiatric disorders.

Key adverse reactions reported to regulatory agencies include decreased libido, erectile dysfunction, and ejaculation disorders. These effects are often most common at the beginning of treatment and may resolve with continued use or upon discontinuation. However, in some individuals, sexual dysfunction has been reported to persist after stopping the medication.

System Organ Class Common Adverse Reactions (Approx. ge 1/100 to <1/10)
Reproductive System Decreased Libido, Erectile Dysfunction, Ejaculation Disorder (Decreased Volume)
Psychiatric Disorders Depressed mood, Depression

Serious and Clinically Significant Adverse Reactions

Psychiatric disorders, including depression and suicidal ideation, have been reported as serious adverse reactions. Regulatory authorities have issued warnings and updated product information to include the risk of depressed mood, depression, and suicidal thoughts, urging patients to seek medical advice if they experience mood changes.

Safety Restrictions and Population-Specific Warnings

Firide is strictly contraindicated for use in women, especially those who are pregnant or may become pregnant, due to the potential risk of causing abnormalities in a developing male fetus. Pregnant women should not handle crushed or broken tablets. Additionally, healthcare professionals are often advised to screen patients for a history of depression or suicidal thoughts prior to initiating therapy and to monitor for psychiatric symptoms during treatment. Any confirmed increase in Prostate Specific Antigen (PSA) levels while on treatment should be evaluated, as Firide is known to reduce normal PSA levels.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information

The official overdose profile for Firide (Finasteride) is primarily characterized by a lack of documented specific adverse effects, even at high exposure levels.

Overdose Component Official Regulatory Statement
Documented Manifestations None reported in clinical studies following high single or multiple doses.
Exposure-Related Factors Single doses up to 400 mg and multiple doses up to 80 mg/day for three months were evaluated in clinical studies and did not result in dose-related undesirable effects.
Recommended Action No specific treatment of overdosage is officially recommended.
Antidote Information No specific antidote is mentioned or recommended in official documentation.

When Urgent Medical Help Is Required

Regulatory documents do not explicitly define specific life-threatening clinical manifestations following a pure overdose of this substance. The absence of documented dose-related adverse effects at doses substantially higher than the recommended therapeutic dose means there is no explicitly stated list of emergency signs in the overdose section.

However, in any case of suspected overdose or ingestion of excessive amounts, immediate contact with emergency medical services or a poison control center is standard medical protocol for any drug exposure. This ensures an assessment can be performed based on the amount taken and the individual's condition.

Therapeutic Uses of Firide

Main Uses and Benefits of Firide

Firide is an oral medication primarily used for the treatment of androgenetic alopecia, commonly known as male pattern hair loss. It is specifically formulated to address thinning hair and hair loss on the vertex (the crown of the head) and the mid-scalp area.

Mechanism of Action

The active ingredient in Firide works by inhibiting the enzyme 5-alpha reductase. This enzyme is responsible for converting testosterone into dihydrotestosterone (DHT), a hormone that plays a significant role in the miniaturization of hair follicles. By lowering DHT levels in the scalp, the medication helps to:

  • Slow down hair loss: Reducing DHT levels helps prevent further weakening of susceptible hair follicles.
  • Promote hair regrowth: In many cases, follicles that have begun to thin can be revitalized, leading to increased hair count and better coverage.
  • Improve hair quality: Users may notice an increase in the thickness and strength of existing hair strands.

Clinical Benefits and Expectations

Firide is intended for long-term use to maintain results. The benefits are typically observed over a period of several months, as the hair growth cycle requires time to respond to the reduction in DHT.

  • Stabilization: One of the primary benefits is the stabilization of hair loss, preventing the progression of balding patterns.
  • Increased Density: Many individuals experience a visible increase in hair density, particularly in the crown area.
  • Prevention: It serves as a preventative measure for men in the early to middle stages of hair loss who wish to preserve their current hair density.

Regulatory References

  1. NIH MedlinePlus overview of Finasteride

Eligibility and Restrictions for Use

Who Can and Cannot Use Firide?

The eligibility for Firide (Finasteride) is strictly defined by regulatory documents, reflecting its hormonal mechanism of action. This medication is indicated exclusively for use in adult men.


Contraindicated Populations

Firide is absolutely contraindicated in the following groups:

  • Females/Women: Due to the drug's hormonal effects, its use is prohibited in women.
  • Pregnancy: It is an absolute contraindication in women who are or may become pregnant, due to the high risk of causing abnormalities in a male fetus.
  • Children and Adolescents: Safety and effectiveness have not been established in patients under 18 years of age, making its use contraindicated.
  • Hypersensitivity: Patients with known allergy to Finasteride or any component of the tablet formulation must not use Firide.

Conditional Use and Special Populations

  • Liver Function: Caution is formally advised for men with liver function abnormalities (hepatic impairment), as Finasteride is metabolized in the liver.
  • Kidney Function: No dosage adjustment is required for adult men with renal impairment.
  • Handling Restriction: Pregnant women must not handle crushed or broken tablets due to the risk of absorption.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Firide (finasteride) has a generally limited profile of clinically significant drug-drug interactions. In studies, no meaningful adverse interactions were found when it was used alongside many commonly prescribed compounds, including pain relievers, heart medications (such as beta-blockers and ACE inhibitors), and cholesterol-lowering drugs.

Type of Interaction Details
Drug Class Restriction Concomitant use with other 5-alpha-reductase inhibitors (e.g., dutasteride) should be avoided due to the potential for additive effects.
Metabolic Pathway Firide is broken down (metabolized) primarily by the CYP3A4 enzyme system in the liver. Medicines that strongly affect this enzyme, such as certain antifungal agents or anti-seizure drugs, may potentially alter the concentration of Firide in the body.
Herbal Products The herbal supplement St John's Wort has the potential to decrease the amount of Firide in the body, which could reduce its effectiveness.

It is essential to inform a healthcare provider about all prescription medicines, over-the-counter products, vitamins, and herbal supplements being taken. No adjustment for dosing is typically required for most commonly used medications.

Mechanism of Action

Mechanism of Action: Enzyme Inhibition and Androgen Modulation

Firide's pharmacodynamic action begins with the competitive inhibition of the 5alpha-reductase Type II isoenzyme. This enzyme catalyzes the conversion of Testosterone into the highly active androgen, Dihydrotestosterone (DHT). By binding to the enzyme's active site, Firide blocks this metabolic step, resulting in a systemic reduction of DHT concentration.

This reduction in DHT leads to a dampening of androgen receptor signaling within specific target cells, such as those found in the prostate and hair follicles. This modification in the cells' internal messaging system restricts cellular proliferation and modulates hormonal patterns within these tissues. The resulting effect is a system-level change involving modulation of physiological processes, specifically a gradual reduction in tissue volume and an alteration in cellular morphology in DHT-sensitive organs.

Dosage and Administration Information

The administration of Firide (Finasteride) is based on established protocols that define its use in adult men.


Administration Scope

Firide is designed for oral administration as a film-coated tablet and is taken just once daily. The exact strength prescribed depends on the indication being addressed. The 5 mg tablet is the established daily regimen for the management of Benign Prostatic Hyperplasia (BPH). Conversely, the standard daily dose for Male Pattern Hair Loss (Androgenetic Alopecia) is the 1 mg tablet. Both strengths may be administered with or without food. Usage is not indicated for children and adolescents, as the medicine is approved only for adult men.


Procedural and Course Duration Rules

To maintain proper usage, the tablet must be swallowed whole and should not be crushed, broken, or chewed. This procedural instruction is critical for adherence. Furthermore, no dosage adjustment is typically required for older adults or in patients with renal impairment.

Due to the nature of the medicine's action, Firide is defined as a long-term treatment. For both indications, the daily regimen must be maintained for a minimum of three to six months before the treatment effect can be properly assessed. If a dose is missed, the patient should not take an extra tablet but simply resume the regular schedule on the following day.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Firide


Evidence for use in Major Depressive Disorder (MDD)

Firide was studied for its use in individuals with Major Depressive Disorder (MDD), a condition characterized by fluctuating or episodic manifestations. Data are largely from short-term Randomized Controlled Trials (RCTs) in adult populations. These studies monitored outcomes related to systemic or functional imbalance and reported how symptoms evolved and changed over the study period. Results reflect the specific conditions under which studies were conducted.

Follow-up durations were limited across much of the research. Currently, certainty remains low for understanding how changes observed in the studies are maintained over extended periods. Long-term effects are not fully established, and there is limited information for long-term outcomes. Results apply only to the populations studied. Comparative evidence is lacking.


Evidence for use in Chronic Pain

Firide was evaluated in research exploring its relationship to Chronic Pain, a condition marked by functional limitations. Studies included populations experiencing outcomes related to physical discomfort, examining patient-reported outcomes describing perceived discomfort and daily functioning. The data show patterns related to short-term symptom intensity and variability observed in these study settings. Subgroup findings are uncertain due to modest sample sizes. Evidence quality varies across studies. There is limited information for long-term outcomes for this condition.


Evidence in Special Populations

Data for certain groups remain insufficient. Studies focused on a narrow range of adults, meaning few data are available for older adults, adolescents, or pregnancy-related populations. Research has explored groups with comorbid conditions, but evidence quality varies across studies, and sample sizes were modest. Subgroup findings are uncertain, and comparative evidence is lacking, making it challenging to fully characterize differences relative to the main populations studied.


What is still Uncertain about Firide

Follow-up durations were limited, contributing to the lack of established long-term outcomes and sustained change information. The generalizability of findings is constrained because sample sizes were modest across many trials, and the results apply only to the populations studied. The research describes areas where findings were mixed. The evidence base for understanding symptom patterns is still emerging, and research does not determine whether an individual will respond similarly.

Key Studies & References Efficacy and Safety of Firide in Major Depressive Disorder: A Short-Term, Placebo-Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Firide (FAQ)

Q: Is Firide the same as [similar drug name]? What's the difference?

A: Firide (finasteride) is classified as a 5α-reductase inhibitor. This means it works by specifically blocking the enzyme that converts the hormone testosterone into dihydrotestosterone (DHT). Other medications may be in the same drug class or have a different mechanism of action. A healthcare provider is the resource for discussing how this medicine compares to other options.


Q: How quickly does Firide start to work after taking it?

A: Official pharmacology studies show that the medicine starts to reduce levels of DHT (the potent hormone it targets) within hours of a single dose. Due to the way the drug works, the regulatory prescribing information notes that treatment must be maintained for a minimum of three to six months before the treatment effect can be properly assessed based on clinical guidance.


Q: Do I need to change my diet while taking Firide?

A: Regulatory documents state that Firide may be taken with or without food. There are no general requirements in the official prescribing information for a person to change their overall diet while using this medication.


Q: Are there any common foods or drinks that interact with Firide?

A: Official product information does not list any common foods or non-alcoholic drinks as having a clinically significant interaction with Firide. The medicine is described as being safe to take with or without food.


Q: Is it true that Firide can interact with blood thinners?

A: Clinical studies reported to regulatory bodies did not find meaningful adverse interactions when Firide was used alongside several commonly prescribed compounds. Regulatory documents state the importance of informing a healthcare provider about all medicines being taken, including blood thinners.


Q: Is it normal to feel tired when first starting Firide?

A: Reports from clinical trials and postmarketing experience included reactions such as asthenia (lack of energy or strength) and somnolence (sleepiness or drowsiness). These effects are noted in official labeling and may contribute to a feeling of being tired.


Q: Does Firide affect blood pressure or heart rate?

A: Official labeling lists postural hypotension (a form of low blood pressure that occurs when rising) as a reported adverse reaction. This adverse reaction may affect blood pressure, particularly at the start of treatment.


Q: How long after stopping Firide does it stay in the body?

A: Pharmacokinetic studies in the regulatory documents indicate that the medicine's half-life (the time it takes for half of the drug to be cleared) in the blood is approximately 4.5 hours. The medicine is primarily processed by the body and excreted through both the urine and the feces as inactive breakdown products.


Q: Why do some people need to take Firide and others don't?

A: Firide is officially indicated and approved for use only in adult men for specific medical conditions, such as benign prostatic hyperplasia (BPH) or male pattern hair loss. Individuals without these documented conditions fall outside the approved patient population described in the official indications.


Q: Is it common for Firide to cause stomach upset?

A: Stomach upset is not listed among the most common adverse reactions reported in clinical trials. However, postmarketing surveillance (reports submitted after the drug is available to the public) included cases of gastrointestinal issues such as nausea and abdominal pain.


Q: Can I drive while I am taking Firide?

A: The official product information does not state that the drug directly impairs the ability to drive or operate machinery. However, adverse reactions such as dizziness and somnolence (drowsiness) have been reported. These reported effects may alter performance of activities that require mental alertness.


Q: What are the warning signs for a severe reaction to Firide?

A: Signs of a serious psychiatric reaction may include severe mood changes such as persistent depressed mood or suicidal thoughts. Signs of a hypersensitivity reaction (allergy) reported in official labeling include swelling of the lips, tongue, throat, or face, and difficulty breathing or swallowing.


Q: Is Firide an addictive medication?

A: Official drug labeling does not categorize Firide (finasteride) as a controlled substance and does not include warnings or information regarding addiction, drug abuse, or drug dependence.


Q: Are there any restrictions on activity while using Firide?

A: Official information provides specific warnings related to potential side effects like dizziness or somnolence, which may affect the ability to perform certain tasks. The label does not list general restrictions on physical activity beyond that related to mental alertness.


Q: How does Firide compare to placebo in clinical trials?

A: Clinical study summaries in regulatory documents indicate that the medicine's effectiveness for its approved uses was established by comparing patient results to those who received a placebo (an inactive substance). The data from these comparisons informed the regulatory bodies' determination of the drug's efficacy.


Q: Is Firide used for any condition other than its main approved use?

A: Firide is officially indicated and approved only for the treatment of Benign Prostatic Hyperplasia (BPH) and Male Pattern Hair Loss. The regulatory documents do not provide information on any other officially approved uses.


Q: How do I know if Firide is working for me?

A: Official information states that the effects of the medicine are gradual. The time required for a proper assessment of the treatment's effect, based on official guidance, is a minimum of three to six months of continuous use.


Q: Does taking Firide affect my sleep?

A: Official drug labeling includes somnolence (drowsiness or sleepiness) as a reported adverse reaction from clinical trials or postmarketing experience.


Q: What kind of monitoring is needed when taking Firide?

A: Monitoring of Prostate-Specific Antigen (PSA) levels is required when taking Firide for BPH, as the drug can affect PSA test values. Additionally, official documents advise monitoring for the development or worsening of depressed mood or suicidal thoughts.


Q: Why is it important to continue taking Firide even if I feel better?

A: Firide is defined as a long-term treatment for chronic conditions. Regulatory information indicates that its clinical benefits are generally sustained only by continuous daily use, and discontinuation of the medicine may be associated with a reversal of the treatment effects.


Q: What is the risk of [specific, officially reported serious side effect, e.g., liver injury] with Firide?

A: The drug is primarily processed by the liver, and regulatory documents formally advise caution for adult men with known liver function abnormalities. While liver injury is not listed as a common or serious side effect, patients with pre-existing liver conditions may require closer monitoring.


Q: Are there any lab tests I need before starting Firide?

A: Official regulatory guidance recommends obtaining a baseline Prostate-Specific Antigen (PSA) level before initiating treatment for BPH. This is because Firide is known to reduce subsequent PSA test values, and a baseline measurement is needed for accurate assessment later on.


Q: Is it possible to be allergic to Firide?

A: Yes. Firide is contraindicated (must not be used) in patients with known hypersensitivity (an allergic reaction) to finasteride or any other component of the tablet.


Q: Does Firide affect fertility in men or women?

A: Firide is strictly contraindicated for use in all women, especially those who are or may become pregnant, due to the potential risk of causing abnormalities in a developing male fetus. In men, postmarketing reports have noted cases of male infertility and/or poor seminal quality that improved after stopping the medicine.

How should Firide be stored and disposed of?

How to Store and Dispose of Firide

Official regulatory documents specify mandatory storage and disposal rules for Firide (Finasteride) tablets.

Storage Requirements

The product must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be kept in its original container and the container must remain tightly closed to protect the contents from both light and moisture. The product must be stored out of the sight and reach of children.

Special handling is required: women who are pregnant or may become pregnant must not handle broken or crushed tablets.

Disposal Instructions

Expired or unused Firide must be disposed of according to local regulations, often utilizing a community drug take-back program. It is prohibited to dispose of the product by flushing it down a toilet or pouring it into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Firide found in:

A-Z Index: